Geschäft · 28.10.20261 Min. Lesezeit
MolecuLight Named Frost & Sullivan's 2026 Global Company of the Year in Wound Imaging
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
Recognition highlights FDA approvals, improved patient outcomes, clinical evidence, integrated wound imaging, and commitment to customer support PITTSBURGH, Oct.